​

Funding Round

Post-IPO Debt - Inozyme

Post-IPO Debt - Inozyme

Investment Firm

Overview

Inozyme is a provider of therapies for rare diseases of calcification affecting soft tissues and bone created to offer potentially.

Announced Date

Jul 26, 2022

Funding Type

Post Ipo Debt

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

K2 HealthVentures

K2 HealthVentures

K2 HealthVentures is a debt and early_stage_venture and late_stage_venture and post_ipo and private_equity firm.

Participant Investors

1

Investor Name
Participant InvestorK2 HealthVentures

Round Details and Background

Inozyme raised $70000000 on 2022-07-26 in Post-IPO Debt

Inozyme is a provider of therapies for rare diseases of calcification affecting soft tissues and bone created to offer potentially.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 09, 2018
Venture Round - Inozyme
-33.7M
Jul 26, 2022
Post-IPO Debt - Inozyme
1-70.0M
Jul 27, 2023
Post-IPO Equity - Inozyme
-60.0M
Apr 14, 2022
Post-IPO Equity - Inozyme
-73.0M

Recent Activity

There is no recent news or activity for this profile.